Analystreport

Celldex Therapeutics, Inc. (NASDAQ: CLDX) had its "hold" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $3.00 price target on the stock.

Celldex Therapeutics, Inc.  (CLDX) 
Last celldex therapeutics, inc. earnings: 11/12 08:01 am Check Earnings Report
US:NASDAQ Investor Relations: ir.celldex.com